Wszolek ZK - Search Results

1

Pathogenic Lrrk2 substitutions and Amyotrophic lateral sclerosis.

Whittle AJ, Ross OA, Naini A, Gordon P, Mistumoto H, Dächsel JC, Stone JT, Wszolek ZK, Farrer MJ, Przedborski S. Whittle AJ, et al. Among authors: wszolek zk. J Neural Transm (Vienna). 2007 Mar;114(3):327-9. doi: 10.1007/s00702-006-0525-3. Epub 2006 Jul 25. J Neural Transm (Vienna). 2007. PMID: 16865326

2

Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes.

West AB, Zimprich A, Lockhart PJ, Farrer M, Singleton A, Holtom B, Lincoln S, Hofer A, Hill L, Müller-Myhsok B, Wszolek ZK, Hardy J, Gasser T. West AB, et al. Among authors: wszolek zk. Eur J Hum Genet. 2001 Sep;9(9):659-66. doi: 10.1038/sj.ejhg.5200698. Eur J Hum Genet. 2001. PMID: 11571553

3

The human sideroflexin 5 (SFXN5) gene: sequence, expression analysis and exclusion as a candidate for PARK3.

Lockhart PJ, Holtom B, Lincoln S, Hussey J, Zimprich A, Gasser T, Wszolek ZK, Hardy J, Farrer MJ. Lockhart PJ, et al. Among authors: wszolek zk. Gene. 2002 Feb 20;285(1-2):229-37. doi: 10.1016/s0378-1119(02)00402-x. Gene. 2002. PMID: 12039050

4

Hereditary tauopathies and parkinsonism.

Wszolek ZK, Tsuboi Y, Farrer M, Uitti RJ, Hutton ML. Wszolek ZK, et al. Adv Neurol. 2003;91:153-63. Adv Neurol. 2003. PMID: 12442674 Review. No abstract available.

5

SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings.

Furtado S, Farrer M, Tsuboi Y, Klimek ML, de la Fuente-Fernández R, Hussey J, Lockhart P, Calne DB, Suchowersky O, Stoessl AJ, Wszolek ZK. Furtado S, et al. Among authors: wszolek zk. Neurology. 2002 Nov 26;59(10):1625-7. doi: 10.1212/01.wnl.0000035625.19871.dc. Neurology. 2002. PMID: 12451209 Clinical Trial.

6

Accurate determination of ataxin-2 polyglutamine expansion in patients with intermediate-range repeats.

Hussey J, Lockhart PJ, Seltzer W, Wszolek ZK, Payami H, Hanson M, Gwinn-Hardy K, Farrer M. Hussey J, et al. Among authors: wszolek zk. Genet Test. 2002 Fall;6(3):217-20. doi: 10.1089/109065702761403397. Genet Test. 2002. PMID: 12490063

7

Two large Polish kindreds with levodopa-responsive Parkinsonism not linked to known Parkinsonian genes and loci.

Krygowska-Wajs A, Hussey JM, Hulihan M, Farrer MJ, Tsuboi Y, Uitti RJ, Wszolek ZK. Krygowska-Wajs A, et al. Among authors: wszolek zk. Parkinsonism Relat Disord. 2003 Mar;9(4):193-200. doi: 10.1016/s1353-8020(02)00036-6. Parkinsonism Relat Disord. 2003. PMID: 12618053

8

Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications.

Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M, Maraganore D, Gwinn-Hardy K, Wszolek Z, Dickson D, Langston JW. Farrer M, et al. Ann Neurol. 2004 Feb;55(2):174-9. doi: 10.1002/ana.10846. Ann Neurol. 2004. PMID: 14755720

9

Autosomal dominant parkinsonism associated with variable synuclein and tau pathology.

Wszolek ZK, Pfeiffer RF, Tsuboi Y, Uitti RJ, McComb RD, Stoessl AJ, Strongosky AJ, Zimprich A, Müller-Myhsok B, Farrer MJ, Gasser T, Calne DB, Dickson DW. Wszolek ZK, et al. Neurology. 2004 May 11;62(9):1619-22. doi: 10.1212/01.wnl.0000125015.06989.db. Neurology. 2004. PMID: 15136696

10

Parkinsonism, FXTAS, and FMR1 premutations.

Toft M, Aasly J, Bisceglio G, Adler CH, Uitti RJ, Krygowska-Wajs A, Lynch T, Wszolek ZK, Farrer MJ. Toft M, et al. Among authors: wszolek zk. Mov Disord. 2005 Feb;20(2):230-3. doi: 10.1002/mds.20297. Mov Disord. 2005. PMID: 15390127

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

699 results

Search Page